MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.

* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 

Deferasirox treatment for myelodysplastic syndromes: real-life efficacy and safety in a single-institution patient population

Breccia M et al. – The oral iron chelator deferasirox is effective and safe when used in myelodysplastic syndromes (MDS) patients with transfusion requirement, also if administered concomitantly with other drugs. [more...]


The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List